It is a new and very rare genetic disorder
characterized by:
Retinal dystrophy,
Optic nerve edema,
Splenomegaly,
Anhidrosis and migraine
Headache.
It belongs to the autoinflammatory diseases, those diseases cause
errors in the innate immune system.
Innate immune system is the first defense of our immune system. It
is a non-specific response but very powerful against the pathogen
agents. It is a double edged sword, it protects the body against the
external world, but it can also sometimes damage the body.
ROSAH Syndrome was documented for the first time in 2012 and has
been officialized in 2019 thanks to genetic doctors. Because of this
discovery, ROSAH patients will be no longer lost in their diagnosis
and no longer seen as a puzzle by their doctors.
We can now fit the puzzle pieces together.
No effective treatment exists for the moment, but we are now
hopeful!